Intra-Cellular Therapies Inc (ITCI)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: ITCI Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2023-11-14	2023-11-13	PS Planned sale	Halstead Michael EVP and General Counsel Officer	8,933 -17.9% 53.37 476,754 USD	8,933 -17.9%	53.37	476,754 USD
2023-11-08	2023-11-06	S Sale	Neumann Mark EVP, Chief Commercial Officer Officer	15,639 -34.5% 55.02 860,417 USD	15,639 -34.5%	55.02	860,417 USD
2023-11-08	2023-11-06	S Sale	Neumann Mark EVP, Chief Commercial Officer Officer	26,754 -37.1% 55.98 1,497,734 USD	26,754 -37.1%	55.98	1,497,734 USD
2023-09-19	2023-09-19	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	44,413 -4.1% 54.17 2,405,852 USD	44,413 -4.1%	54.17	2,405,852 USD
2023-09-19	2023-09-18	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	28,119 -2.5% 53.96 1,517,301 USD	28,119 -2.5%	53.96	1,517,301 USD
2023-09-19	2023-09-18	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	27,468 -2.4% 53.55 1,470,911 USD	27,468 -2.4%	53.55	1,470,911 USD
2023-08-09	2023-08-07	S Sale	Neumann Mark EVP, Chief Commercial Officer Officer	55,300 -54.9% 58.79 3,251,087 USD	55,300 -54.9%	58.79	3,251,087 USD
2023-07-20	2023-07-17	PS Planned sale	Durgam Suresh K. EVP, Chief Medical Officer Officer	1,842 -8.0% 65.00 119,730 USD	1,842 -8.0%	65.00	119,730 USD
2023-06-16	2023-06-14	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	3,592 -100.0% 65.01 233,516 USD	3,592 -100.0%	65.01	233,516 USD
2023-06-16	2023-06-14	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	44,035 -92.5% 64.37 2,834,533 USD	44,035 -92.5%	64.37	2,834,533 USD
2023-06-16	2023-06-14	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	34,227 -41.8% 63.35 2,168,280 USD	34,227 -41.8%	63.35	2,168,280 USD
2023-04-19	2023-04-17	PS Planned sale	VAN NOSTRAND ROBERT L Non-Executive Director	10,000 -51.7% 63.00 630,000 USD	10,000 -51.7%	63.00	630,000 USD
2023-03-30	2023-03-28	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	10,183 -18.3% 54.01 549,984 USD	10,183 -18.3%	54.01	549,984 USD
2023-03-30	2023-03-28	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	5,421 -8.9% 54.86 297,396 USD	5,421 -8.9%	54.86	297,396 USD
2023-03-13	2023-03-13	PS Planned sale	Durgam Suresh K. EVP, Chief Medical Officer Officer	346 -1.5% 44.29 15,324 USD	346 -1.5%	44.29	15,324 USD
2023-03-13	2023-03-13	PS Planned sale	Durgam Suresh K. EVP, Chief Medical Officer Officer	6,998 -23.0% 45.08 315,470 USD	6,998 -23.0%	45.08	315,470 USD
2023-03-13	2023-03-13	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	1,412 -0.1% 44.08 62,241 USD	1,412 -0.1%	44.08	62,241 USD
2023-03-13	2023-03-13	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	19,153 -1.7% 45.06 863,034 USD	19,153 -1.7%	45.06	863,034 USD
2023-03-13	2023-03-13	PS Planned sale	Halstead Michael EVP and General Counsel Officer	476 -100.0% 44.15 21,015 USD	476 -100.0%	44.15	21,015 USD
2023-03-13	2023-03-13	PS Planned sale	Halstead Michael EVP and General Counsel Officer	6,868 -93.5% 44.99 308,991 USD	6,868 -93.5%	44.99	308,991 USD
2023-03-13	2023-03-13	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	258 -100.0% 44.14 11,388 USD	258 -100.0%	44.14	11,388 USD
2023-03-13	2023-03-13	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	5,324 -95.4% 44.97 239,420 USD	5,324 -95.4%	44.97	239,420 USD
2023-03-13	2023-03-13	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	423 -0.7% 44.05 18,633 USD	423 -0.7%	44.05	18,633 USD
2023-03-13	2023-03-13	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	3,335 -5.2% 45.10 150,409 USD	3,335 -5.2%	45.10	150,409 USD
2023-03-13	2023-03-10	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	6,805 -0.6% 42.51 289,281 USD	6,805 -0.6%	42.51	289,281 USD
2023-03-13	2023-03-10	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	34,965 -3.0% 43.28 1,513,285 USD	34,965 -3.0%	43.28	1,513,285 USD
2023-03-13	2023-03-10	PS Planned sale	Halstead Michael EVP and General Counsel Officer	2,500 -100.0% 42.52 106,300 USD	2,500 -100.0%	42.52	106,300 USD
2023-03-13	2023-03-10	PS Planned sale	Halstead Michael EVP and General Counsel Officer	14,208 -85.0% 43.20 613,786 USD	14,208 -85.0%	43.20	613,786 USD
2023-03-13	2023-03-10	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	2,700 -100.0% 42.52 114,804 USD	2,700 -100.0%	42.52	114,804 USD
2023-03-13	2023-03-10	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	12,963 -82.8% 43.17 559,613 USD	12,963 -82.8%	43.17	559,613 USD
2023-03-13	2023-03-10	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	1,800 -3.0% 42.74 76,932 USD	1,800 -3.0%	42.74	76,932 USD
2023-03-13	2023-03-10	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	6,750 -10.2% 43.50 293,625 USD	6,750 -10.2%	43.50	293,625 USD
2023-03-03	2023-03-01	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	7,241 -12.8% 50.01 362,122 USD	7,241 -12.8%	50.01	362,122 USD
2023-02-27	2023-02-24	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	7,455 -100.0% 47.03 350,609 USD	7,455 -100.0%	47.03	350,609 USD
2023-02-27	2023-02-24	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	22,590 -2.0% 47.03 1,062,408 USD	22,590 -2.0%	47.03	1,062,408 USD
2023-02-27	2023-02-24	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	4,046 -6.7% 47.12 190,648 USD	4,046 -6.7%	47.12	190,648 USD
2023-02-27	2023-02-24	PS Planned sale	Durgam Suresh K. SVP, Chief Medical Officer Officer	7,906 -25.5% 47.14 372,689 USD	7,906 -25.5%	47.14	372,689 USD
2023-02-27	2023-02-24	PS Planned sale	Halstead Michael EVP and General Counsel Officer	7,906 -100.0% 47.03 371,819 USD	7,906 -100.0%	47.03	371,819 USD
2023-02-22	2023-02-21	PS Planned sale	Halstead Michael EVP and General Counsel Officer	100 -100.0% 49.60 4,960 USD	100 -100.0%	49.60	4,960 USD
2023-02-22	2023-02-21	PS Planned sale	Halstead Michael EVP and General Counsel Officer	1,100 -91.7% 48.68 53,548 USD	1,100 -91.7%	48.68	53,548 USD
2023-02-22	2023-02-21	PS Planned sale	Halstead Michael EVP and General Counsel Officer	643 -34.9% 47.23 30,369 USD	643 -34.9%	47.23	30,369 USD
2023-02-22	2023-02-21	PS Planned sale	Halstead Michael EVP and General Counsel Officer	9,296 -83.5% 46.56 432,822 USD	9,296 -83.5%	46.56	432,822 USD
2023-02-22	2023-02-21	PS Planned sale	Durgam Suresh K. SVP, Chief Medical Officer Officer	75 -0.3% 49.60 3,720 USD	75 -0.3%	49.60	3,720 USD
2023-02-22	2023-02-21	PS Planned sale	Durgam Suresh K. SVP, Chief Medical Officer Officer	806 -3.4% 48.63 39,196 USD	806 -3.4%	48.63	39,196 USD
2023-02-22	2023-02-21	PS Planned sale	Durgam Suresh K. SVP, Chief Medical Officer Officer	800 -3.2% 47.20 37,760 USD	800 -3.2%	47.20	37,760 USD
2023-02-22	2023-02-21	PS Planned sale	Durgam Suresh K. SVP, Chief Medical Officer Officer	6,673 -21.2% 46.55 310,628 USD	6,673 -21.2%	46.55	310,628 USD
2023-02-22	2023-02-21	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	635 -1.2% 48.93 31,071 USD	635 -1.2%	48.93	31,071 USD
2023-02-22	2023-02-21	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	123 -0.2% 47.32 5,820 USD	123 -0.2%	47.32	5,820 USD
2023-02-22	2023-02-21	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	3,140 -5.6% 46.61 146,355 USD	3,140 -5.6%	46.61	146,355 USD
2023-02-22	2023-02-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	94 -100.0% 49.60 4,662 USD	94 -100.0%	49.60	4,662 USD
2023-02-22	2023-02-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	900 -90.5% 48.72 43,848 USD	900 -90.5%	48.72	43,848 USD
2023-02-22	2023-02-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	800 -44.6% 47.32 37,856 USD	800 -44.6%	47.32	37,856 USD
2023-02-22	2023-02-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	8,649 -82.8% 46.54 402,524 USD	8,649 -82.8%	46.54	402,524 USD
2023-02-22	2023-02-21	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	251 -0.0% 49.60 12,450 USD	251 -0.0%	49.60	12,450 USD
2023-02-22	2023-02-21	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	2,502 -0.2% 48.70 121,847 USD	2,502 -0.2%	48.70	121,847 USD
2023-02-22	2023-02-21	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	2,200 -0.2% 47.35 104,170 USD	2,200 -0.2%	47.35	104,170 USD
2023-02-22	2023-02-21	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	22,895 -2.0% 46.54 1,065,533 USD	22,895 -2.0%	46.54	1,065,533 USD
2023-02-22	2023-02-17	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	1,689 -100.0% 50.59 85,447 USD	1,689 -100.0%	50.59	85,447 USD
2023-02-22	2023-02-17	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	52,279 -96.9% 49.81 2,604,017 USD	52,279 -96.9%	49.81	2,604,017 USD
2022-12-21	2022-12-19	S Sale	MARCUS JOEL S Non-Executive Director	5,000 -14.6% 50.82 254,100 USD	5,000 -14.6%	50.82	254,100 USD
2022-12-15	2022-12-13	PS Planned sale	Mates Sharon Chairman, President & CEO Executive Director	33,083 -2.9% 55.00 1,819,565 USD	33,083 -2.9%	55.00	1,819,565 USD
2022-12-02	2022-12-01	PS Planned sale	Halstead Michael EVP and General Counsel Officer	22,796 -100.0% 53.48 1,219,130 USD	22,796 -100.0%	53.48	1,219,130 USD
2022-12-02	2022-12-01	PS Planned sale	Halstead Michael EVP and General Counsel Officer	27,204 -54.4% 53.94 1,467,384 USD	27,204 -54.4%	53.94	1,467,384 USD
2022-11-08	2022-11-07	S Sale	MARCUS JOEL S Non-Executive Director	5,000 -12.7% 52.11 260,559 USD	5,000 -12.7%	52.11	260,559 USD
2022-11-08	2022-11-07	S Sale	MARCUS JOEL S Non-Executive Director	5,000 -11.3% 52.49 262,465 USD	5,000 -11.3%	52.49	262,465 USD
2022-09-23	2022-09-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	33,303 -100.0% 45.39 1,511,623 USD	33,303 -100.0%	45.39	1,511,623 USD
2022-09-23	2022-09-21	PS Planned sale	Hineline Lawrence J. SVP of Finance CFO Officer	31,861 -48.9% 45.88 1,461,783 USD	31,861 -48.9%	45.88	1,461,783 USD
2022-08-12	2022-08-11	S Sale	VAN NOSTRAND ROBERT L Non-Executive Director	1,500 -14.2% 56.80 85,200 USD	1,500 -14.2%	56.80	85,200 USD
2022-08-12	2022-08-11	S Sale	VAN NOSTRAND ROBERT L Non-Executive Director	28,500 -73.0% 57.15 1,628,775 USD	28,500 -73.0%	57.15	1,628,775 USD
2022-08-12	2022-08-11	S Sale	MARCUS JOEL S Non-Executive Director	10,000 -18.4% 59.22 592,200 USD	10,000 -18.4%	59.22	592,200 USD
2022-05-13	2022-05-12	S Sale	MARCUS JOEL S Non-Executive Director	10,000 -15.6% 55.00 550,000 USD	10,000 -15.6%	55.00	550,000 USD
2022-04-08	2022-04-08	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	14,885 -24.7% 65.14 969,609 USD	14,885 -24.7%	65.14	969,609 USD
2022-04-08	2022-04-08	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	53,987 -47.3% 64.42 3,477,843 USD	53,987 -47.3%	64.42	3,477,843 USD
2022-04-08	2022-04-08	PS Planned sale	Neumann Mark EVP, Chief Commercial Officer Officer	17,476 -13.3% 63.55 1,110,600 USD	17,476 -13.3%	63.55	1,110,600 USD
2022-03-18	2022-03-18	S Sale	RIGGS RORY B Non-Executive Director	15,736 -100.0% 61.35 965,352 USD	15,736 -100.0%	61.35	965,352 USD